Briacell Therapeutics Corp Stock Market Value
| BCTXZ Stock | 0.17 0.02 13.33% |
| Symbol | BriaCell |
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BriaCell Therapeutics. Projected growth potential of BriaCell fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive BriaCell Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of BriaCell Therapeutics is measured differently than its book value, which is the value of BriaCell that is recorded on the company's balance sheet. Investors also form their own opinion of BriaCell Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is BriaCell Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BriaCell Therapeutics' market value can be influenced by many factors that don't directly affect BriaCell Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between BriaCell Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BriaCell Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, BriaCell Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
BriaCell Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BriaCell Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BriaCell Therapeutics.
| 11/23/2025 |
| 02/21/2026 |
If you would invest 0.00 in BriaCell Therapeutics on November 23, 2025 and sell it all today you would earn a total of 0.00 from holding BriaCell Therapeutics Corp or generate 0.0% return on investment in BriaCell Therapeutics over 90 days. BriaCell Therapeutics is related to or competes with NewcelX, XORTX Therapeutics, Elevai Labs, Virax Biolabs, Ainos, Dermata Therapeutics, and Avenue Therapeutics. BriaCell Therapeutics is entity of United States More
BriaCell Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BriaCell Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BriaCell Therapeutics Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 69.68 | |||
| Value At Risk | (22.22) | |||
| Potential Upside | 18.52 |
BriaCell Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BriaCell Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BriaCell Therapeutics' standard deviation. In reality, there are many statistical measures that can use BriaCell Therapeutics historical prices to predict the future BriaCell Therapeutics' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (1.58) | |||
| Treynor Ratio | 0.4687 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BriaCell Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
BriaCell Therapeutics February 21, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | 0.4787 | |||
| Mean Deviation | 9.4 | |||
| Coefficient Of Variation | (3,134) | |||
| Standard Deviation | 12.63 | |||
| Variance | 159.44 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (1.58) | |||
| Treynor Ratio | 0.4687 | |||
| Maximum Drawdown | 69.68 | |||
| Value At Risk | (22.22) | |||
| Potential Upside | 18.52 | |||
| Skewness | (0.47) | |||
| Kurtosis | 1.16 |
BriaCell Therapeutics Backtested Returns
At this stage we consider BriaCell Stock to be out of control. BriaCell Therapeutics secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. We have found twenty-four technical indicators for BriaCell Therapeutics Corp, which you can use to evaluate the volatility of the firm. Please confirm BriaCell Therapeutics' Standard Deviation of 12.63, mean deviation of 9.4, and Risk Adjusted Performance of (0.01) to double-check if the risk estimate we provide is consistent with the expected return of 0.0657%. The firm shows a Beta (market volatility) of -0.88, which signifies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning BriaCell Therapeutics are expected to decrease slowly. On the other hand, during market turmoil, BriaCell Therapeutics is expected to outperform it slightly. BriaCell Therapeutics right now shows a risk of 13.57%. Please confirm BriaCell Therapeutics kurtosis, market facilitation index, and the relationship between the value at risk and rate of daily change , to decide if BriaCell Therapeutics will be following its price patterns.
Auto-correlation | -0.05 |
Very weak reverse predictability
BriaCell Therapeutics Corp has very weak reverse predictability. Overlapping area represents the amount of predictability between BriaCell Therapeutics time series from 23rd of November 2025 to 7th of January 2026 and 7th of January 2026 to 21st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BriaCell Therapeutics price movement. The serial correlation of -0.05 indicates that only as little as 5.0% of current BriaCell Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.05 | |
| Spearman Rank Test | -0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BriaCell Stock Analysis
When running BriaCell Therapeutics' price analysis, check to measure BriaCell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BriaCell Therapeutics is operating at the current time. Most of BriaCell Therapeutics' value examination focuses on studying past and present price action to predict the probability of BriaCell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BriaCell Therapeutics' price. Additionally, you may evaluate how the addition of BriaCell Therapeutics to your portfolios can decrease your overall portfolio volatility.